JAMA Editors' Summary cover image

Semaglutide for Weight Loss, Ivermectin for Mild COVID-19, USPSTF Guideline on Screening for Vitamin D Deficiency, and more

JAMA Editors' Summary

00:00

Introduction

Exploring the results of two randomized trials on Semaglutide, a GLP1 receptor agonist, for weight management in adults with overweight or obesity.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app